We are live on
!
Find out more
BIG
Brooklyn Investment Group Portfolio holdings
AUM
$3.2B
1-Year Est. Return
26.32%
This Fund
S&P 500
This Quarter
Est. Return
+1.57%
1 Year Est. Return
+26.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.2B
AUM Growth
+$1.03B
(+48%)
Cap. Flow
+$1.12B
Cap. Flow
% of AUM
35.09%
Top 10 Holdings %
Top 10 Hldgs %
23.2%
Holding
2,041
New
543
Increased
1,055
Reduced
218
Closed
214
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$55.1M |
| 2 |
Apple
AAPL
|
+$48.2M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$32.7M |
| 4 |
Microsoft
MSFT
|
+$23.6M |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$6.55M |
| 2 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$3.23M |
| 3 |
Polen Capital Global Growth ETF
PCGG
|
+$3.04M |
| 4 |
HDFC Bank
HDB
|
+$2.48M |
| 5 |
Pulse Biosciences
PLSE
|
+$2.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Financials | 11.47% |
| 3 | Consumer Discretionary | 8.66% |
| 4 | Industrials | 8.57% |
| 5 | Healthcare | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
ASP Isotopes
ASPI
$509M
| $83.4K | ﹤0.01% |
+18,868
| New | +$112K |
|
|
MPT
1802
Medical Properties Trust
MPT
$2.87B
| $81.8K | ﹤0.01% |
17,665
-33,907
| -66% | -$177K |
|
1803
Burford Capital
BUR
$909M
| $81.4K | ﹤0.01% |
+18,007
| New | +$158K |
|
|
FINV
1804
FinVolution Group
FINV
$1.11B
| $80.9K | ﹤0.01% |
16,894
-550
| -3% | -$2.92K |
|
1805
FTAI Infrastructure
FIP
$519M
| $79.1K | ﹤0.01% |
+16,009
| New | +$89.7K |
|
1806
Grocery Outlet
GO
$884M
| $76.5K | ﹤0.01% |
+10,853
| New | +$94.3K |
|
1807
Palladyne AI
PDYN
$247M
| $76.1K | ﹤0.01% |
+12,540
| New | +$84.9K |
|
1808
Asana
ASAN
$1.51B
| $68.3K | ﹤0.01% |
+10,668
| New | +$93.9K |
|
1809
JetBlue
JBLU
$1.86B
| $66.8K | ﹤0.01% |
15,122
+4,483
| +42% | +$22.7K |
|
1810
QuantumScape Corp
QS
$3.15B
| $66.1K | ﹤0.01% |
+10,362
| New | +$86.1K |
|
|
DCH
1811
Dauch Corp
DCH
$1.33B
| $65.4K | ﹤0.01% |
+11,030
| New | +$76.7K |
|
1812
Oportun Financial
OPRT
$244M
| $65.3K | ﹤0.01% |
+14,169
| New | +$72.1K |
|
1813
LG Display
LPL
$3.37B
| $62.3K | ﹤0.01% |
+16,057
| New | +$67.9K |
|
1814
Granite Ridge Resources
GRNT
$650M
| $62.2K | ﹤0.01% |
+10,597
| New | +$53.2K |
|
1815
Iovance Biotherapeutics
IOVA
$2.29B
| $61.9K | ﹤0.01% |
+17,635
| New | +$56.4K |
|
1816
Xeris Biopharma Holdings
XERS
$1.45B
| $61.1K | ﹤0.01% |
10,534
-1,661
| -14% | -$11K |
|
1817
Krispy Kreme
DNUT
$536M
| $55.5K | ﹤0.01% |
16,357
-4,678
| -22% | -$16.1K |
|
|
BBBY
1818
Bed Bath & Beyond
BBBY
$471M
| $50.3K | ﹤0.01% |
+10,844
| New | +$60.7K |
|
1819
Myriad Genetics
MYGN
$538M
| $50.1K | ﹤0.01% |
+11,136
| New | +$58K |
|
|
TEF
1820
DELISTED
Telefonica
TEF
| $46.9K | ﹤0.01% |
10,727
-11,336
| -51% | -$44.4K |
|
|
INN
1821
Summit Hotel Properties
INN
$749M
| $45.2K | ﹤0.01% |
+10,232
| New | +$45.9K |
|
1822
Rocket Pharmaceuticals
RCKT
$358M
| $42.3K | ﹤0.01% |
11,825
-7,374
| -38% | -$29.3K |
|
1823
Gerdau
GGB
$9.36B
| $40.3K | ﹤0.01% |
+11,170
| New | +$43.9K |
|
1824
CEMIG Preferred Shares
CIG
$6.21B
| $34.1K | ﹤0.01% |
+14,269
| New | +$31.4K |
|
1825
Heron Therapeutics
HRTX
$86.9M
| $12.7K | ﹤0.01% |
+15,927
| New | +$18.5K |
|
Similar funds
HCM
SC
YCM
KIM
DCM
MPW
SYBT
FAM
Brooklyn Investment Group's Q1 2026 Portfolio in Review
As of Q1 2026, Brooklyn Investment Group held 2,041 positions worth $3.2B, up 48% from $2.17B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brooklyn Investment Group deployed $1.12B of net new capital in Q1 2026, opening 543 new positions and adding to 1,055 existing holdings. Its largest new stake was Moog Inc Class A: 12,841 shares worth $3.76M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was AstraZeneca, an estimated $6.55M trimmed.
- Brooklyn Investment Group's largest Q1 2026 buy was Moog Inc Class A: 12,841 shares worth $3.76M.
- Brooklyn Investment Group added most to NVIDIA in Q1 2026, an estimated $55.1M increase.
- Brooklyn Investment Group's biggest Q1 2026 reduction was AstraZeneca, cutting an estimated $6.55M.
- Brooklyn Investment Group fully exited Polen Capital Global Growth ETF in Q1 2026, selling an estimated $3.04M.
- Brooklyn Investment Group's ten largest holdings make up 23% of its $3.2B portfolio in Q1 2026.
- Brooklyn Investment Group opened 543 new positions and closed 214 in Q1 2026.
- Brooklyn Investment Group's portfolio value rose 48% quarter-over-quarter to $3.2B.
Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.